FBB Biomed files provisional patent with the US Patent and Trademark Office
FBB Biomed’s reagent enables novel next-generation sequencing (NGS) diagnostics. A FBB test provides neurologists with a liquid biopsy for brain diseases.
Our test runs on standard laboratory sequencing equipment and protocols. No new hardware or processes required.
"Which specific neurologic disease does this patient have?"
"How effective has the therapy been for this specific patient?"
© 2023 All Rights Reserved